FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely to the agents possessing antituberculous action and used in phthisiology. The tablet contains 1-isonicotinyl-2-glucosylhydrazone dihydrate (isoglucosyl), hydroxypropylmethylcellulose or methylcellulose and calcium stearate. The tablet can be covered by a cover. The invention provides high therapeutic efficiency and hypotoxicity of the new agent in comparison with known antituberculous forms of Isoniaside and rifampicin.
EFFECT: provision of high therapeutic efficiency and hypotoxicity of the new agent in comparison with known antituberculous forms of Isoniaside and rifampicin.
2 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
TUBERCULOUS AGENT AS SOLUTION FOR INJECTION | 2007 |
|
RU2358742C2 |
SUPPOSITORY FOR TUBERCULOSIS TREATMENT | 2007 |
|
RU2363474C2 |
METHOD FOR PRODUCING POLYMERIC COMPLEX | 2010 |
|
RU2435611C1 |
METHOD FOR PRODUCING POLYMER CONJUGATE OF ISONICOTINIC ACID HYDRAZONE | 2010 |
|
RU2454226C1 |
METHOD FOR PREPARING 1-ISONICOTINYL-2-D-GLUCOSYL HYDRAZONE POSSESSING WITH ANTITUBERCULOSIS ACTIVITY | 2004 |
|
RU2279438C2 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 |
|
RU2424808C2 |
COMBINED ANTI-TUBERCULOSIS PREPARATION | 2007 |
|
RU2354378C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
ANTI-TUBERCULOSIS MEDICATION | 2010 |
|
RU2424809C1 |
Authors
Dates
2009-08-10—Published
2007-10-10—Filed